CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 226,300 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 211,190 shares at $2.99 ($631,099)
- 4 Open-market sale Chief Medical Officer sold 4,083 shares at $2.99 ($12,196)
- 4 Open-market sale Chief Scientific Officer sold 4,370 shares at $2.99 ($13,053)
- 4 Open-market sale Chief Operations Officer sold 4,370 shares at $2.99 ($13,053)
- 4 Open-market sale President and CEO sold 17,196 shares at $2.99 ($51,363)
- 4 Open-market buy Director bought 3,821,273 shares at an average $3.06 ($11,687,810)
- 4 Grant or award Chief Medical Officer acquired 13,750 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 13,750 shares (grant or award)
- 4 Grant or award Chief Operations Officer acquired 13,750 shares (grant or award)
- 4 Grant or award President and CEO acquired 37,500 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $3.03 ($15,127)
- 4 Open-market buy Director bought 7,000 shares at $2.96 ($20,723)
- 4 Open-market buy Director bought 17,200 shares at $2.95 ($50,664)
- 4 Open-market sale President and CEO sold 4,746 shares at $2.96 ($14,065)
- 4 Open-market sale Chief Medical Officer sold 3,636 shares at $4.39 ($15,962)
Page 9 of 21 · 410 filings